View in EDS HTML Full Text PDF Full Text

The kidney injury biomarker profile of patients with lupus nephritis remains unchanged with the second-generation calcineurin inhibitor voclosporin.

Saved in:
Bibliographic Details
Title: The kidney injury biomarker profile of patients with lupus nephritis remains unchanged with the second-generation calcineurin inhibitor voclosporin.
Authors: Palmer BF; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, United States., Tumlin JA; NephroNet Clinical Research Consortium, Atlanta, GA, United States., Radhakrishnan J; Division of Nephrology, Columbia University Medical Center, New York, NY, United States., Rehaume LM; Aurinia Pharmaceuticals Inc., Edmonton, AB, Canada., Cross JL; Aurinia Pharmaceuticals Inc., Edmonton, AB, Canada., Huizinga RB; Aurinia Pharmaceuticals Inc., Edmonton, AB, Canada.
Source: Frontiers in nephrology [Front Nephrol] 2025 Mar 17; Vol. 5, pp. 1540471. Date of Electronic Publication: 2025 Mar 17 (Print Publication: 2025).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 9918469487906676 Publication Model: eCollection Cited Medium: Internet ISSN: 2813-0626 (Electronic) Linking ISSN: 28130626 NLM ISO Abbreviation: Front Nephrol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40166657
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The kidney injury biomarker profile of patients with lupus nephritis remains unchanged with the second-generation calcineurin inhibitor voclosporin.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Palmer+BF%22">Palmer BF</searchLink>; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, United States.<br /><searchLink fieldCode="AU" term="%22Tumlin+JA%22">Tumlin JA</searchLink>; NephroNet Clinical Research Consortium, Atlanta, GA, United States.<br /><searchLink fieldCode="AU" term="%22Radhakrishnan+J%22">Radhakrishnan J</searchLink>; Division of Nephrology, Columbia University Medical Center, New York, NY, United States.<br /><searchLink fieldCode="AU" term="%22Rehaume+LM%22">Rehaume LM</searchLink>; Aurinia Pharmaceuticals Inc., Edmonton, AB, Canada.<br /><searchLink fieldCode="AU" term="%22Cross+JL%22">Cross JL</searchLink>; Aurinia Pharmaceuticals Inc., Edmonton, AB, Canada.<br /><searchLink fieldCode="AU" term="%22Huizinga+RB%22">Huizinga RB</searchLink>; Aurinia Pharmaceuticals Inc., Edmonton, AB, Canada.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229918469487906676%22">Frontiers in nephrology</searchLink> [Front Nephrol] 2025 Mar 17; Vol. 5, pp. 1540471. <i>Date of Electronic Publication: </i>2025 Mar 17 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media+S%2EA%22">Frontiers Media S.A </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>9918469487906676 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2813-0626 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2228130626%22">28130626 </searchLink><i>NLM ISO Abbreviation: </i>Front Nephrol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40166657
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fneph.2025.1540471
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1540471
    Titles:
      – TitleFull: The kidney injury biomarker profile of patients with lupus nephritis remains unchanged with the second-generation calcineurin inhibitor voclosporin.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Palmer BF
      – PersonEntity:
          Name:
            NameFull: Tumlin JA
      – PersonEntity:
          Name:
            NameFull: Radhakrishnan J
      – PersonEntity:
          Name:
            NameFull: Rehaume LM
      – PersonEntity:
          Name:
            NameFull: Cross JL
      – PersonEntity:
          Name:
            NameFull: Huizinga RB
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 17
              M: 03
              Text: 2025 Mar 17
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2813-0626
          Numbering:
            – Type: volume
              Value: 5
          Titles:
            – TitleFull: Frontiers in nephrology
              Type: main
ResultId 1